| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 对乙酰胺基酚可直压颗粒(元) | 126,992,961.60 | 254,254,607.56 | 114,402,014.35 | 306,640,842.52 | 178,953,413.87 |
| 对乙酰胺基酚原料药(元) | 80,344,891.90 | 166,107,120.14 | 89,706,582.27 | 311,209,474.80 | 208,708,338.50 |
| 其他原料药(元) | 10,357,836.32 | 14,531,729.02 | 7,503,303.17 | 20,013,777.70 | 9,420,042.35 |
| 其他制剂(元) | 3,133,329.85 | 8,000,749.20 | 3,841,208.97 | 10,611,138.28 | 6,826,777.41 |
| 营业成本(元) | |||||
| 对乙酰胺基酚可直压颗粒(元) | 80,828,487.32 | 154,361,464.49 | 66,336,628.37 | 193,662,354.92 | 117,301,572.07 |
| 对乙酰胺基酚原料药(元) | 47,624,937.85 | 88,094,360.19 | 48,351,546.12 | 180,034,903.09 | 124,183,473.03 |
| 其他原料药(元) | 6,157,352.56 | 7,725,023.14 | 4,041,505.72 | 8,331,869.68 | 3,305,861.42 |
| 其他制剂(元) | 2,083,626.61 | 5,475,883.69 | 2,612,934.83 | 5,613,314.04 | 2,820,319.36 |
| 毛利(元) | |||||
| 对乙酰胺基酚可直压颗粒(元) | 46,164,474.28 | 99,893,143.07 | 48,065,385.98 | 112,978,487.60 | 61,651,841.80 |
| 对乙酰胺基酚原料药(元) | 32,719,954.05 | 78,012,759.95 | 41,355,036.15 | 131,174,571.71 | 84,524,865.47 |
| 其他原料药(元) | 4,200,483.76 | 6,806,705.88 | 3,461,797.45 | 11,681,908.02 | 6,114,180.93 |
| 其他制剂(元) | 1,049,703.24 | 2,524,865.51 | 1,228,274.14 | 4,997,824.24 | 4,006,458.05 |
| 毛利率(%) | |||||
| 对乙酰胺基酚可直压颗粒(%) | 36.35 | 39.29 | 42.01 | 36.84 | 34.45 |
| 对乙酰胺基酚原料药(%) | 40.72 | 46.97 | 46.10 | 42.15 | 40.50 |
| 其他原料药(%) | 40.55 | 46.84 | 46.14 | 58.37 | 64.91 |
| 其他制剂(%) | 33.50 | 31.56 | 31.98 | 47.10 | 58.69 |
| 收入构成(%) | |||||
| 对乙酰胺基酚可直压颗粒(%) | 57.51 | 57.41 | 53.10 | 47.29 | 44.31 |
| 对乙酰胺基酚原料药(%) | 36.38 | 37.50 | 41.64 | 47.99 | 51.67 |
| 其他原料药(%) | 4.69 | 3.28 | 3.48 | 3.09 | 2.33 |
| 其他制剂(%) | 1.42 | 1.81 | 1.78 | 1.64 | 1.69 |
| 毛利构成(%) | |||||
| 对乙酰胺基酚可直压颗粒(%) | 54.87 | 53.35 | 51.07 | 43.31 | 39.45 |
| 对乙酰胺基酚原料药(%) | 38.89 | 41.67 | 43.94 | 50.29 | 54.08 |
| 其他原料药(%) | 4.99 | 3.64 | 3.68 | 4.48 | 3.91 |
| 其他制剂(%) | 1.25 | 1.35 | 1.31 | 1.92 | 2.56 |